| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2025 | Dec 12, 2025 | PharmaCyte Biotech, Inc. | Director | Sell | 95.0 | +82,500 | 165.00% | ✗ | $68.9K |
| Nov 14, 2025 | Nov 17, 2025 | Oblong, Inc. | Director | Buy | 91.3 | +10,000 | 66.67% | ✗ | $19.1K |
| Sep 17, 2025 | Sep 17, 2025 | Oblong, Inc. | Director | Buy | 91.3 | +5,000 | 50.00% | ✗ | $13.5K |
| Sep 16, 2025 | Sep 16, 2025 | Oblong, Inc. | Director | Buy | 91.3 | +10,000 | 100.00% | ✗ | $27.3K |
| Jun 30, 2025 | Jul 2, 2025 | TAO Synergies Inc. | Director | Sell | 95.0 | +12,945 | 1187.61% | ✗ | $67.7K |
| Dec 16, 2022 | Dec 20, 2022 | TAO Synergies Inc. | Director | Sell | 13.8 | -20,250 | -41.54% | ✓ | $23.7K |